Nykode Therapeutics Stock
Stocks
VACC
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.290 NOK | 0.00% |
|
-2.66% | +36.40% |
| 07/08 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
| 05/08 | Nykode Therapeutics Flags Delay in Draft Recommendation for Tax Appeal in Norway | MT |
| Market Cap | 1.07B 113M 98M 91.75M 83.71M 158M 10.79B 160M 1.08B 421M 5.4B 425M 415M 18.01B | P/E 2026 * |
-5.09x | P/E 2027 * | -35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 589M 62.03M 53.75M 50.32M 45.91M 86.4M 5.92B 87.85M 590M 231M 2.96B 233M 228M 9.88B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.07x |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nykode Therapeutics
| 1 week | -2.66% | ||
| Current month | -2.66% | ||
| 1 month | +15.03% | ||
| 3 months | +5.11% | ||
| 6 months | -13.78% | ||
| Current year | +36.40% |
| 1 week | 3.21 |  | 3.38 |
| 1 month | 2.66 | | 3.56 |
| Current year | 2.21 | | 4.1 |
| 1 year | 1.44 | | 4.1 |
| 3 years | 1.44 | | 30.18 |
| 5 years | 1.44 | | 85.3 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 01/01/2019 |
| President | 49 | 01/01/2017 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 03/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 23/04/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/3/25 | Buy | Company | 3,000,000 | 0.9187% | ||
| 20/12/24 | Buy | Director | 100,000 | 0.0306% | ||
| 20/12/24 | Sell | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.66% | +97.01% | -88.92% | 113M | |
| -0.70% | +13.34% | +75.61% | +103.83% | 70.51B | |
| -2.35% | +2.88% | +35.39% | +64.72% | 54.05B | |
| -1.62% | +34.25% | +17.43% | +491.04% | 28.95B | |
| -1.39% | +11.52% | +53.25% | +6.46% | 24.05B | |
| 0.00% | +1.59% | -15.06% | -13.21% | 23.31B | |
| +0.05% | +6.12% | +46.81% | -21.81% | 18.37B | |
| +9.77% | +20.16% | +260.17% | +472.38% | 18.67B | |
| -0.28% | +6.95% | +30.33% | +620.55% | 16.1B | |
| -3.08% | -8.34% | +37.21% | +138.52% | 12.72B | |
| Average | +0.01% | +356.34% | +63.81% | +177.36% | 26.68B | |
| Weighted average by Cap. | -0.46% | +350.00% | +57.59% | +168.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 162M 17.02M 14.75M 13.81M 12.6M 23.71M 1.62B 24.11M 162M 63.44M 813M 63.91M 62.52M 2.71B |
| Net income | -208M -21.88M -18.97M -17.75M -16.2M -30.49M -2.09B -31M -208M -81.57M -1.04B -82.17M -80.38M -3.49B | -41.58M -4.38M -3.79M -3.55M -3.24M -6.1M -417M -6.2M -41.64M -16.31M -209M -16.43M -16.08M -697M |
| Net Debt | -485M -51.06M -44.25M -41.43M -37.8M -71.13M -4.87B -72.33M -486M -190M -2.44B -192M -188M -8.13B | -578M -60.79M -52.68M -49.32M -45M -84.68M -5.8B -86.1M -578M -227M -2.9B -228M -223M -9.68B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | NOK 3.290 | -0.30% | 220,292 |
| 10/08/26 | NOK 3.300 | -0.90% | 341,054 |
| 07/08/26 | NOK 3.330 | +3.42% | 567,193 |
| 06/08/26 | NOK 3.220 | +0.31% | 677,752 |
| 05/08/26 | NOK 3.210 | -5.03% | 658,828 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VACC Stock
Select your edition
All financial news and data tailored to specific country editions
